Page last updated: 2024-11-03

riluzole and Constriction, Pathological

riluzole has been researched along with Constriction, Pathological in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"Neuropathic pain is becoming an intractable health threat, with its profound effect on quality of life, thus posing a major challenge to clinical therapy."1.43Effects of riluzole on P2X7R expression in the spinal cord in rat model of neuropathic pain. ( Chen, H; Ge, AQ; Jiang, K; Miao, B; Sun, L; Yan, M; Zhuang, Y, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, K1
Zhuang, Y1
Yan, M1
Chen, H1
Ge, AQ1
Sun, L1
Miao, B1

Other Studies

1 other study available for riluzole and Constriction, Pathological

ArticleYear
Effects of riluzole on P2X7R expression in the spinal cord in rat model of neuropathic pain.
    Neuroscience letters, 2016, Apr-08, Volume: 618

    Topics: Animals; Constriction, Pathologic; Hyperalgesia; Male; Microglia; Neuralgia; Purinergic P2X Receptor

2016